Physician profile
Myron L Hall
NPI 1114964970
$2,109.68
in general payments reported to CMS, 2019-2025
15 companies · $628 in 2025
The $628 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $51.57 · 2021: $134 · 2022: $369 · 2023: $325 · 2024: $602 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,228 · Debt Forgiveness: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.91 |
| Debt Forgiveness | $326.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $965.19 | 2021-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Djo, LLC | $326.76 | 2024 | |
| Organogenesis INC. | $300.36 | 2023-2025 | Apligraf, Puraply Antimicrobial, Puraply |
| Novartis Pharmaceuticals Corporation | $112.45 | 2020-2022 | |
| Cardiovascular Systems INC. | $100.57 | 2022 | |
| Integra Lifesciences Corporation | $74.05 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $56.17 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Globus Medical, INC. | $35.07 | 2023 | Evo Retrograde |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.51 | 2023 | Jardiance |
| Solventum Corporation | $24.38 | 2025 | Activ.A.C. |
| Medtronic, INC. | $23.03 | 2024 | Accurian |
| Paragon 28, INC. | $19.72 | 2024 | |
| Orthofix Medical, INC. | $18.07 | 2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $14.94 | 2020 | |
| Wright Medical Technology, INC. | $12.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Myron Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.